BRIM Biotechnology, Inc. (TPE:6885)
Taiwan
· Delayed Price · Currency is TWD 24.90
-0.95 (-3.68%)
At close: Mar 9, 2026
BRIM Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | -387.7 | -315.47 | -688.02 | -274.28 | -105.45 | -87.94 | Upgrade
|
| Depreciation & Amortization | 35.27 | 9.25 | 5.41 | 3.97 | 3.82 | 3.81 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -0.01 | - | - | -48.79 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -32.87 | -26.77 | Upgrade
|
| Loss (Gain) on Equity Investments | 19.46 | 27.03 | 24.59 | 62.62 | 47.94 | 9.66 | Upgrade
|
| Stock-Based Compensation | 54.22 | 39.17 | 47.78 | 35.32 | 7.07 | 2.33 | Upgrade
|
| Other Operating Activities | 5.73 | -13.82 | -4.38 | 0.24 | 0.27 | -18.09 | Upgrade
|
| Change in Accounts Receivable | -3.13 | -3.1 | -1.41 | -0.32 | -0.01 | 2.44 | Upgrade
|
| Change in Accounts Payable | -16.93 | -16.07 | 19.67 | 4.14 | -31.77 | 37.27 | Upgrade
|
| Change in Unearned Revenue | 1 | - | - | - | -1.12 | 1.12 | Upgrade
|
| Change in Other Net Operating Assets | -323.19 | -6.23 | -0.51 | -3.57 | -0.45 | -2.16 | Upgrade
|
| Operating Cash Flow | -615.25 | -279.24 | -596.89 | -171.87 | -112.57 | -127.12 | Upgrade
|
| Capital Expenditures | -1.27 | -2.9 | -2.26 | -1.11 | -0.78 | -0.37 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.01 | - | - | - | Upgrade
|
| Divestitures | - | - | - | - | - | -137.57 | Upgrade
|
| Sale (Purchase) of Intangibles | -76.24 | -77.08 | -1.44 | -0.11 | - | - | Upgrade
|
| Investment in Securities | 160.61 | -585.18 | -747.63 | 23.84 | 119.34 | - | Upgrade
|
| Other Investing Activities | 35.66 | -0.32 | -0.11 | 0 | -0 | -2.29 | Upgrade
|
| Investing Cash Flow | 123.16 | -665.48 | -751.43 | 22.63 | 118.56 | -140.23 | Upgrade
|
| Long-Term Debt Repaid | - | -4.16 | -4.18 | -3.68 | -3.6 | -3.51 | Upgrade
|
| Net Debt Issued (Repaid) | -22.43 | -4.16 | -4.18 | -3.68 | -3.6 | -3.51 | Upgrade
|
| Issuance of Common Stock | 500.44 | 503.64 | 1,463 | 591.16 | 314.33 | 1.02 | Upgrade
|
| Financing Cash Flow | 478.01 | 499.49 | 1,458 | 587.49 | 310.73 | -2.49 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.02 | - | - | - | - | 5.96 | Upgrade
|
| Net Cash Flow | -14.05 | -445.24 | 110.01 | 438.24 | 316.72 | -263.88 | Upgrade
|
| Free Cash Flow | -616.52 | -282.14 | -599.15 | -172.98 | -113.35 | -127.48 | Upgrade
|
| Free Cash Flow Margin | -19436.26% | -84726.73% | -665723.33% | -32885.74% | -31485.83% | -140.45% | Upgrade
|
| Free Cash Flow Per Share | -4.78 | -2.42 | -5.96 | -2.43 | -1.91 | -2.17 | Upgrade
|
| Cash Interest Paid | 0.36 | 0.09 | 0.15 | 0.08 | 0.11 | 0.07 | Upgrade
|
| Cash Income Tax Paid | - | - | -0.07 | -0.13 | -0.05 | 9.13 | Upgrade
|
| Levered Free Cash Flow | -250.39 | 50.82 | -371.06 | -97.94 | -81.3 | -55.43 | Upgrade
|
| Unlevered Free Cash Flow | -250.16 | 50.88 | -370.97 | -97.89 | -81.23 | -55.39 | Upgrade
|
| Change in Working Capital | -342.22 | -25.39 | 17.75 | 0.25 | -33.34 | 38.67 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.